Targeted Electromagnetic Stimulation for Non-Neurological Applications

Publication ID: 24-11857275_0007_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Targeted Electromagnetic Stimulation for Non-Neurological Applications,” Published Technical Disclosure No. 24-11857275_0007_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857275_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,275.

Summary of the Inventive Concept

A novel approach applying the core technology of targeted neuromodulation to various non-neurological fields, including agriculture, veterinary medicine, and athletic performance, to enhance growth, treat diseases, and improve cognitive abilities.

Background and Problem Solved

The original patent focused on neuromodulation therapy for treating mental conditions in humans. However, the core technology has the potential to be applied to other industries and fields. The new inventive concept addresses the limitations of the original patent by expanding its application to non-neurological domains, where targeted electromagnetic stimulation can have a significant impact.

Detailed Description of the Inventive Concept

The new inventive concept utilizes the same processor and memory containing a targeting application as the original patent, but adapts it to obtain crop data, animal brain data, or athletic performance data. The application then directs the processor to apply electromagnetic stimulation to specific regions of the crop, animal brain, or athlete's brain to achieve the desired outcome. This includes enhancing growth and yield in crops, treating plant diseases, enhancing cognitive abilities in animals, improving athletic performance, and treating neurological disorders in veterinary medicine.

Novelty and Inventive Step

The new claims introduce a non-obvious and novel application of the core technology to non-neurological fields, which is distinct from the original patent's focus on neuromodulation therapy for mental conditions in humans.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of electromagnetic stimulation, such as transcranial magnetic stimulation or transcranial direct current stimulation, or integrating the technology with other systems, like precision agriculture or wearable devices. Variations may also involve adapting the technology for use in different species or applications, such as treating diseases in livestock or enhancing cognitive abilities in companion animals.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in various industries, including agriculture, veterinary medicine, and sports technology. The target market includes companies and organizations focused on precision agriculture, animal health, and human performance enhancement, as well as research institutions and universities exploring new applications of electromagnetic stimulation.

CPC Classifications

SectionClassGroup
A A61 A61B34/20
A A61 A61B5/0036
A A61 A61B5/055
A A61 A61N1/20
A A61 A61N1/36096
A A61 A61N2/006
G G01 G01R33/4806
G G01 G01R33/5608

Original Patent Information

Patent NumberUS 11,857,275
TitleSystems and methods for targeted neuromodulation
Assignee(s)The Board of Trustees of the Leland Stanford Junior University